Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Coinbase
COIN
|
+$862M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$853M |
| 3 |
Meta Platforms (Facebook)
META
|
+$641M |
| 4 |
Intel
INTC
|
+$547M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$518M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.09B |
| 2 |
Tesla
TSLA
|
+$1.13B |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$756M |
| 4 |
Dell
DELL
|
+$641M |
| 5 |
ProShares UltraPro QQQ
TQQQ
|
+$631M |
Sector Composition
| 1 | Technology | 16.48% |
| 2 | Consumer Discretionary | 10.12% |
| 3 | Financials | 9.46% |
| 4 | Healthcare | 7.62% |
| 5 | Communication Services | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5501
Offerpad Solutions
OPAD
$133M
| $33.6K | ﹤0.01% |
+11,794
| New | +$33.6K |
|
|
ZOOZ
5502
ZOOZ Power
ZOOZ
$33.7M
| $33.1K | ﹤0.01% |
+13,514
| New | +$33.1K |
|
5503
Freightos
CRGO
$151M
| $33.1K | ﹤0.01% |
+10,850
| New | +$33.1K |
|
5504
NeuroOne Medical Technologies
NMTC
$44.5M
| $33K | ﹤0.01% |
+39,951
| New | +$33K |
|
5505
Cheche Group
CCG
$89.5M
| $32.8K | ﹤0.01% |
+36,856
| New | +$32.8K |
|
5506
XTI Aerospace
XTIA
$31M
| $32.7K | ﹤0.01% |
3,039
+2,987
| +5,744% | +$32.1K |
|
|
NCZ
5507
Virtus Convertible & Income Fund II
NCZ
$262M
| $32.3K | ﹤0.01% |
+2,578
| New | +$32.3K |
|
|
ZDAI
5508
Primega Group Holdings Limited Ordinary Shares
ZDAI
$14.8M
| $32.1K | ﹤0.01% |
+22,774
| New | +$32.1K |
|
|
MIN
5509
MFS Intermediate Income Trust
MIN
$307M
| $32.1K | ﹤0.01% |
12,058
-21,635
| -64% | -$57.5K |
|
5510
SCYNEXIS
SCYX
$47M
| $32.1K | ﹤0.01% |
+26,507
| New | +$32.1K |
|
|
USBC
5511
USBC, Inc.
USBC
$292M
| $31.8K | ﹤0.01% |
+4,613
| New | +$31.8K |
|
|
SLRN
5512
DELISTED
ACELYRIN
SLRN
| $31.5K | ﹤0.01% |
10,031
-79,769
| -89% | -$250K |
|
5513
Bridgeline Digital
BLIN
$16.4M
| $31.2K | ﹤0.01% |
+19,735
| New | +$31.2K |
|
5514
Clean Energy Technologies
CETY
$18M
| $30.7K | ﹤0.01% |
+50,100
| New | +$30.7K |
|
5515
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $30.7K | ﹤0.01% |
22,246
-45,360
| -67% | -$62.6K |
|
|
CMCT
5516
Creative Media & Community Trust
CMCT
$6M
| $30.7K | ﹤0.01% |
545
+473
| +657% | +$26.6K |
|
5517
ProQR Therapeutics
PRQR
$231M
| $30.2K | ﹤0.01% |
+11,400
| New | +$30.2K |
|
5518
IN8bio
INAB
$9.53M
| $29.8K | ﹤0.01% |
3,864
+2,890
| +297% | +$22.3K |
|
5519
Cenntro
CENN
$28M
| $29.8K | ﹤0.01% |
+27,864
| New | +$29.8K |
|
5520
Femasys
FEMY
$12.8M
| $29.8K | ﹤0.01% |
+27,099
| New | +$29.8K |
|
5521
374Water
SCWO
$60.9M
| $29.8K | ﹤0.01% |
43,591
-3,412
| -7% | -$2.33K |
|
|
DRRX
5522
DELISTED
DURECT Corp
DRRX
| $29.4K | ﹤0.01% |
39,196
+28,486
| +266% | +$21.4K |
|
5523
Farmer Brothers
FARM
$39.4M
| $29.4K | ﹤0.01% |
+16,309
| New | +$29.4K |
|
5524
Hyliion Holdings
HYLN
$284M
| $28.8K | ﹤0.01% |
11,038
-254,264
| -96% | -$664K |
|
5525
Context Therapeutics
CNTX
$74.9M
| $28.8K | ﹤0.01% |
+27,395
| New | +$28.8K |
|